ITCI

Intra-Cellular Therapies, Inc.

Phase 3 Estimated

Lumateperone

Bipolar Depression

Countdown

297days

Phase 3 readout · ~ Apr 30, 2027 estimated

What's at stake Phase 3 trial results for Lumateperone in Bipolar Depression are due ~ Apr 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT06372964: Phase 3 trial, sponsor Intra-Cellular Therapies, Inc., drug Lumateperone. Primary completion date 2027-04 (estimated).”

Add to calendar Post on X Reddit

Provenance